Cargando…
The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
N6-methyladenosine (m6A) RNA methylation is an emerging area of epigenetics, which is a reversible and dynamic modification mediating by ‘writers’ (methylase, adding methyl groups, METTL3, METTL14, and WTAP), ‘erasers’ (demethylase, deleting methyl groups, FTO and ALKBH5), and ‘readers’ (YTHDF1-3, Y...
Autores principales: | Zhang, Beijian, Jiang, Hao, Dong, Zhen, Sun, Aijun, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427257/ https://www.ncbi.nlm.nih.gov/pubmed/34522705 http://dx.doi.org/10.1016/j.gendis.2020.07.011 |
Ejemplares similares
-
m6A demethylase FTO attenuates cardiac dysfunction by regulating glucose uptake and glycolysis in mice with pressure overload-induced heart failure
por: Zhang, Beijian, et al.
Publicado: (2021) -
Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
por: Zhang, Beijian, et al.
Publicado: (2021) -
Loss of m6A demethylase ALKBH5 promotes post‐ischemic angiogenesis via post‐transcriptional stabilization of WNT5A
por: Zhao, Yongchao, et al.
Publicado: (2021) -
Impact and potential mechanism of effects of chronic moderate alcohol consumption on cardiac function in aldehyde dehydrogenase 2 gene heterozygous mice
por: Hu, Qinfeng, et al.
Publicado: (2022) -
The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential
por: Zhang, Xiaokai, et al.
Publicado: (2021)